Collaborating Authors

FDA Updates Abortion Pill Guidance

U.S. News

The Food and Drug Administration on Wednesday approved changes to the labeling of the abortion pill mifepristone, potentially allowing more women to access it at a lower price and injecting the agency into a hot-button social debate playing out in states across the country. The new guidance increased the number of days women could take the abortion pill by a week, up to 70 days into a pregnancy. It also cut the drug's dosage by two-thirds, from 600 milligrams to 200 milligrams, a move that decreases the cost . The drug's manufacturer submitted data and information to have the label revised. This type of non-surgical, or "medical," abortion can be conducted at home, and some women chose it because they consider it to be a less-invasive option.

When Abortion Was Illegal, Adoption Was a Cruel Industry. Are We Returning to Those Days?

Mother Jones

And usually, that serves us well in doing the ambitious, hard-hitting journalism that you turn to Mother Jones for. But it also means we can't afford to come up short when it comes to scratching together the funds it takes to keep our team firing on all cylinders, and the truth is, we finished our budgeting cycle on June 30 about $100,000 short of our online goal. This is no time to come up short. It's time to fight like hell, as our namesake would tell us to do, for a democracy where minority rule cannot impose an extreme agenda, where facts matter, and where accountability has a chance at the polls and in the press. If you value our reporting and you can right now, please help us dig out of the $100,000 hole we're starting our new budgeting cycle in with an always-needed and always-appreciated donation today.

Coronavirus fuels abortion debate as states restrict access to procedure

FOX News

Fox News Flash top headlines are here. Check out what's clicking on Get all the latest news on coronavirus and more delivered daily to your inbox. The coronavirus has poured fuel on to the fire of an already raging debate surrounding abortion access as both sides discuss whether pandemic-related restrictions on medical care should apply to abortion clinics, as well. On Tuesday, a long list of pro-life leaders sent a letter demanding that the Health and Human Services Department (HHS) refrain from promoting abortion during the pandemic.

Understanding the abortion industry's greatest lie

FOX News

The greatest lie women have ever been told is that they need abortion in order to achieve their dreams, to have the career they want, to be the movie star they worked so hard to become, to keep their partner. I told this very lie to countless women in order to convince them to pay us at Planned Parenthood to get rid of that growing life inside of them. It is also the same lie that the abortion industry has built their case on in Dobbs vs. Jackson Women's Health Organization. Women, don't believe this lie. At its very core, this lie demands you attain justice and equality at the expense of a human being who shares your DNA, who will have parts of your personality and physical qualities, and whose very existence is a miracle.

New abortion drug label could undo several U.S. state laws

The Japan Times

OKLAHOMA CITY – A federal agency approved a new label for a common abortion-inducing drug that will undermine restrictions on medication abortions passed by several states, allowing women to take the drug later in a pregnancy and with fewer required office visits. The Food and Drug Administration notified the manufacturer of the drug Mifeprex in a letter on Tuesday that the drug is safe and effective for terminating a pregnancy in accordance with the new label. Also known as mifepristone, the drug is used in combination with another drug, misoprostol, to end a pregnancy. While abortion providers in most states already are using the protocol outlined in the new label, laws in effect in Ohio, North Dakota and Texas prohibited "off label" uses of the drug and mandated abortion providers adhere to the older protocol approved in 2000. Similar laws in Arizona, Arkansas and Oklahoma have been on hold pending legal challenges.